High status job means you are less likely to respond to treatment for depression

September 20, 2016, European College of Neuropsychopharmacology

An international study has found that having a high status job means that you are less likely to respond to standard treatment with medications for depression. These results, which may have implications for clinicians and their patients, employers and public policy, are presented at the ECNP Congress in Vienna.

Up to a third of patients who receive drug treat for depression do not respond to treatment. Knowing which groups don't respond could help understand which treatments are appropriate to which person. In the case of workers, it may also enable employers to take steps to ease . Although there is a wealth of research showing that low social and is associated with a greater risk of depression, there has been little work focusing on how occupational levels respond to treatment.

A group of international researchers from Belgium, Italy, Israel and Austria enlisted 654 working adults attending clinics for depression, and classified their work according to occupational level. 336 (51.4%) held high occupational level jobs, 161 (24.6%) middle-level, and 157 (24%) low level. Around two-thirds of the patients were female (65.6%), which reflects the normal gender difference in reported depression. Most patients were treated with SRIs (Serotonin Reuptake Inhibitors), although other pharmaceutical agents were also used, as well as psychotherapy. Those in the higher levels were found to have received fewer SRIs and more psychotherapy.

On analysing results after treatment, they found that 55.9% in the highest occupational group were resistant to treatment. In contrast, only 40.2% of the middle-level workers remained treatment resistant, and 44.3 of the low-level workers. This difference was also reflected in the degree of remission, with only around one in 6 in remission in the higher status group, as against around one in 4 for the other groups.

Commenting, Professor Siegfried Kasper (Vienna, Austria) said "Though these findings should be considered preliminarily, they indicate that high occupational levels may be a risk factor for poor response to treatment. A number of variables may explain these findings. For example, there may be specific working environment demands and stressors; people may find it difficult to accept or cope with illness, or to continue with medication; or there may be other factors, related for example to cognitive, personality and behavioural differences."

Co-worker Professor Joseph Zohar (ECNP Past-President, Tel-Hashomer, Israel) said; "This shows that the need for precise prescribing is not only related to the symptoms and genetics but also to occupational level; one might need to prescribe different medication for the same disorder and need to take into account the occupational level in order to reach optimum effect."

Professor Eduard Vieta (ECNP Executive Committee member and Chair of the Department of Psychiatry and Psychology, Hospital Clinic, University of Barcelona), commented:

"The results of this study might sound counterintuitive, but people with highly demanding jobs are subject to a lot of stress, and when they breakdown with depression it may be particularly difficult to cope with their previous life. An alternative explanation, which cannot be ruled out given the naturalistic design of the study, is that high-status job patients may be more prone to request psychosocial treatments without the support of pharmacotherapy. The ideal treatment of is, in general, the combination of both pharmacotherapy and psychotherapy."

Explore further: Hormone EPO shown to improve brain sharpness in patients with depression and bipolar disorder

More information: Laura Mandelli et al. High occupational level is associated with poor response to treatment of depression, European Neuropsychopharmacology (2016). DOI: 10.1016/j.euroneuro.2016.05.002

Related Stories

Hormone EPO shown to improve brain sharpness in patients with depression and bipolar disorder

September 19, 2016
A study has found that the hormone erythropoietin (EPO) – best known as a performance-enhancing drug in sport – may improve cognitive functioning in patients suffering from bipolar disorder or depression. This raises ...

Less than one-third of adults with depression receive treatment

August 29, 2016
New findings suggest that most Americans with depression receive no treatment, while raising the possibility that overtreatment of depression is also widespread. Less than a third of American adults who screened positive ...

Study shows lack of interest in sex successfully treated by exposure to bright light

September 19, 2016
Exposure to bright light increases testosterone levels and leads to greater sexual satisfaction in men with low sexual desire. These are the results of a pilot randomised placebo-controlled trial, presented at the ECNP conference ...

Specialist mental health services do work—but they come at a price, study finds

August 4, 2016
A specialist service offering a tailored approach to treating patients with severe depression is more effective than usual mental health care but comes at a higher cost, research led by academics at The University of Nottingham ...

Correcting metabolic deficiencies may improve depression symptoms

August 12, 2016
Identifying and treating metabolic deficiencies in patients with treatment-resistant depression can improve symptoms and in some cases even lead to remission, according to new research from the University of Pittsburgh School ...

Work productivity is key factor in assessing recovery of depressed patients

August 15, 2016
While medications can quickly reduce depressive symptoms, monitoring work productivity can provide unique insight into whether a patient will require additional treatments to achieve long-term remission, a new study through ...

Recommended for you

Infants are more likely to learn when with a peer

October 16, 2018
Infants are more likely to learn from on-screen instruction when paired with another infant as opposed to viewing the lesson alone, according to a new study.

Researchers use brain cells in a dish to study genetic origins of schizophrenia

October 16, 2018
A study in Biological Psychiatry has established a new analytical method for investigating the complex genetic origins of mental illnesses using brain cells that are grown in a dish from human embryonic stem cells. Researchers ...

Linguistic red flags from Facebook posts can predict future depression diagnoses

October 15, 2018
In any given year, depression affects more than 6 percent of the adult population in the United States—some 16 million people—but fewer than half receive the treatment they need. What if an algorithm could scan social ...

Early changes to synapse gene regulation may cause Alzheimer's disease

October 15, 2018
Alzheimer's disease (AD) is the most common form of dementia, involving memory loss and a reduction in cognitive abilities. Patients with AD develop multiple abnormal protein structures in their brains that are thought to ...

Clues that suggest people are lying may be deceptive, study shows

October 12, 2018
The verbal and physical signs of lying are harder to detect than people believe, a study suggests.

Why don't we understand statistics? Fixed mindsets may be to blame

October 12, 2018
Unfavorable methods of teaching statistics in schools and universities may be to blame for people ignoring simple solutions to statistical problems, making them hard to solve. This can have serious consequences when applied ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.